Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1970 Jan;55(1):89-103.
doi: 10.1085/jgp.55.1.89.

Calcium and adenosine triphosphate binding to renal membranes

Calcium and adenosine triphosphate binding to renal membranes

R F Palmer et al. J Gen Physiol. 1970 Jan.

Abstract

Calcium binds to membranous structures isolated from rabbit kidney cortex homogenates. The binding is enhanced by ATP and Mg(++) in combination. Other nucleotides, ITP and GTP, do not have this property. In contrast to similar preparations of nerve and muscle, the binding is not augmented by oxalate (3-100 mM). Also, binding of calcium cannot be correlated with ATP hydrolysis. p-Chloromercuribenzoate and the mercurial diuretic agent mercaptomerin inhibit the binding of calcium. This system can be distinguished from the binding of calcium by mitochondria by lack of azide inhibition and by failure of ADP-succinate to substitute for ATP. (14)C- and gamma-(32)P-labeled ATP bind to the renal membranes in the absence of calcium, but only the (32)P binding increases when calcium is added. The ratio of (32)P bound to (45)Ca bound is 2:1. The above data are consistent with a hypothesis that calcium is metabolically bound to renal membranes and that this binding is associated with membrane phosphorylation. Such a formulation may have pertinence to the conformational state of renal membranes and subsequent permeability characteristics. It also allows for the concept that membrane stability requires metabolic participation, as well as calcium ions.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Pharmacol Rev. 1965 Sep;17(3):265-320 - PubMed
    1. Fed Proc. 1966 Nov-Dec;25(6):1804-10 - PubMed
    1. Exp Cell Res. 1967 May;46(2):412-8 - PubMed
    1. J Gen Physiol. 1967 May;50(5):1327-52 - PubMed
    1. J Pharmacol Exp Ther. 1967 Sep;157(3):599-617 - PubMed

MeSH terms